Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: vareniclineFind trials that include: Any drugs shown Results 1-10 of 10 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Behavioral Counseling and Nicotine Replacement Therapy or Varenicline in Helping Smokers Quit Status: ActivePhase: Phase IVType: Behavioral study, Biomarker/Laboratory analysis, PreventionAge: 18 to 65Trial IDs: 2014-0207, NCI-2014-01485, NCT02162849 2. Varenicline and Nicotine Replacement Therapy for Initial Smoking Cessation and Treatment in Smokers Status: ActivePhase: Phase IVType: Behavioral study, PreventionAge: 18 to 65Trial IDs: 2014-0213, NCI-2015-00610, NCT02271919 3. Genetically Informed Smoking Cessation Interventions in Helping People Quit Smoking Status: ActivePhase: Phase IVType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: 201305128, NCI-2015-00792, NCT02351167 4. Varenicline for Smoking Cessation in African American Smokers Status: ActivePhase: Phase IVType: Biomarker/Laboratory analysis, Tissue collection/RepositoryAge: 18 and overTrial IDs: STUDY00000721, NCI-2015-01529, NCT02360631 5. Varenicline for Adolescent Smoking Cessation Status: ActivePhase: Phase IIIType: Biomarker/Laboratory analysis, PreventionAge: 14 to 21Trial IDs: Pro00014398, NCI-2016-02034, NCT01509547 6. Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients with Newly Diagnosed Lung Cancer Who Smoke Cigarettes Status: Not yet activePhase: Phase IIIType: Supportive careAge: 18 and overTrial IDs: A211401, NCI-2016-00438, NCT02856581 7. Strategies to Promote Smoking Cessation in Patients with Newly Diagnosed or Recurrent Lung or Head and Neck Cancer Status: ActivePhase: No phase specifiedType: Behavioral studyAge: 18 and overTrial IDs: KCTN-1301, NCI-2014-00939, NCI-2014-00879, NCT02048917 8. Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients with Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy with or without Chemotherapy Status: ActivePhase: No phase specifiedType: Biomarker/Laboratory analysis, PreventionAge: 18 and overTrial IDs: CCCWFU 98415, NCI-2015-01714, NCT02582008 9. Varenicline or Varenicline-Based Adaptive Pharmacotherapy with High or Low Intensity Behavioral Programs in Helping Smokers Quit Smoking Status: ActivePhase: No phase specifiedType: TreatmentAge: 18 and overTrial IDs: Pro00072077, NCI-2017-00062, NCT02501265 10. Culturally-Tailored Internet-Based Smoking Cessation Program in Quitting Smoking in Tribal College Students Status: ActivePhase: No phase specifiedType: PreventionAge: 18 and overTrial IDs: 13613, NCI-2017-00812, NCT02050308 Select All on Page Start Over
